Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.6K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.6K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

990
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refining microbiome resolution: KoSCAPE<sub>bio</sub> identifies <i>Klebsiella oxytoca</i> complex species in16S rRNA amplicon data and uncovers associations with NEC.

Gut microbes·2025
Same author

Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation.

Nature communications·2025
Same author

Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem.

Gut microbes·2024
Same author

Microbiota regulates neonatal disease tolerance to virus-evoked necrotizing enterocolitis by shaping the STAT1-NLRC5 axis in the intestinal epithelium.

Cell host & microbe·2024
Same author

Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms.

Nature microbiology·2024
Same author

Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in <i>Helicobacter pylori</i> infection.

Frontiers in immunology·2024

Related Experiment Video

Updated: Mar 7, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.6K

Inflammatory disease caused by intestinal pathobionts.

Ellen L Zechner1

  • 1Institute of Molecular Biosciences, University of Graz, Humboldtstrasse 50/1, A-8010 Graz, Austria; BioTechMed-Graz, Austria.

Current Opinion in Microbiology
|February 13, 2017
PubMed
Summary
This summary is machine-generated.

Environmental factors can disrupt gut microbiota balance, leading to inflammatory diseases. Understanding these complex microbial communities is crucial for developing effective treatments to restore a healthy gut environment.

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

69.2K

Related Experiment Videos

Last Updated: Mar 7, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.6K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

69.2K

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Environmental and intrinsic factors can disrupt the gut microbiota's structure.
  • This disruption, known as dysbiosis, can lead to aberrant immune responses and inflammation.
  • Dysbiosis is characterized by an overgrowth of pro-inflammatory microbes and a loss of beneficial commensals.

Purpose of the Study:

  • To understand how polymicrobial communities drive intestinal inflammation.
  • To identify protective mechanisms lost due to the absence of specific commensals.
  • To explore interventions for shifting dysbiotic communities towards a healthier state.

Main Methods:

  • Analysis of microbiota structure and function in disease states.
  • Investigating the role of specific organisms and collective microbial functions.
  • Evaluating interventions aimed at modulating the gut microbial community.

Main Results:

  • Intestinal inflammatory diseases are often driven by the collective functions of polymicrobial communities.
  • Specific organisms can contribute to pathogenicity, but community-level function is key.
  • Loss of beneficial commensals exacerbates the inflammatory state.

Conclusions:

  • Dysbiosis, driven by altered microbiota, is a significant factor in inflammatory diseases.
  • Understanding the complex interplay within microbial communities is essential for therapeutic development.
  • Targeting microbial community structure and function offers potential for treating inflammatory conditions.